Lv4
480 积分 2021-10-12 加入
COPD and multimorbidity: recognising and addressing a syndemic occurrence
4天前
已完结
[Guidelines for peri-discharge management and follow-up of acute exacerbations of chronic obstructive pulmonary disease(2024 edition)]
29天前
已完结
[Transformations and optimizations: updates in the global and domestic guidelines for chronic obstructive pulmonary disease over 25 years]
1个月前
已完结
Moxifloxacin
1个月前
已关闭
Moxifloxacin
1个月前
已关闭
Moxifloxacin
1个月前
已关闭
Oral oseltamivir reduces febrile illness in patients considered at high risk of influenza complications
1个月前
已完结
Management of influenza – updated Swedish guidelines for antiviral treatment
2个月前
已完结
Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis
2个月前
已完结
Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa
2个月前
已完结
皖公网安备34019202002308
